It is incredible how well both Moderna and BioNTech timed their low in October of 2019 just before the Wuhan outbreak. Those fortunate enough to jump in early enjoyed a 3000%+ run over the next 600 days. From a Technical Analysis perspective, I just go, “Hmmmmmm…”